One compound is therefore acting on incretin and hepatic signalling at the level of whole-body energy balance, the other on bioenergetic signalling within the mitochondrion
Lee, W.M., Hynan, L.S., Rossaro, L., Fontana, R.J
We are issuing this fourth final rule to reiterate, and further, our goal of ensuring that pricing information is standardized and easily comparable across hospitals
The case for cost savings to the public purse is also murky
However, we remain concerned about the availability of Ozempic and other TGA-approved diabetes medications and products and, along with our unified partners, the Australian Diabetes Society and Diabetes Australia, we continue to advocate for reliable access for people living with diabetes. Health Minister Mark Butler said that while compounding was valid in certain circumstances, the priority was to ensure safety for Australians
doi: 10.1016/j.pcad.2018.05.004